Concepedia

Judith A. Finlay

JA

Statistics

Publications

16

Citations

832

H-Index

15

Active since

1994

Affiliations

Mayo Clinic(Current)

San Diego Composites (United States)

Beckman Coulter Foundation

Johns Hopkins Hospital

Mayo Clinic in Arizona

Judith A. Finlay is an author at Mayo Clinic specializing in prostate-specific antigen testing, prostate cancer, and oncology.

Publications per year

1994–2006

16

Publications

16

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis

Alan W. Partin, William J. Catàlona, Judith A. Finlay et al. · Urology · 1999 · 135 citations

, , +13

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

William J. Catàlona, Alan W. Partin, Judith A. Finlay et al. · Urology · 1999 · 124 citations

, , +17

The Saccharomyces cerevisiae APS1 gene encodes a homolog of the small subunit of the mammalian clathrin AP‐1 complex: evidence for functional interaction with clathrin at the Golgi complex.

H Phan, Judith A. Finlay, Diana S. Chu et al. · The EMBO Journal · 1994 · 75 citations · Full text

, , +17

PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS

René Raaijmakers, B. G. Blijenberg, Judith A. Finlay et al. · The Journal of Urology · 2004 · 70 citations

, , +17

Development of Monoclonal Antibodies Specific for Human Glandular Kallikrein (hK2): Development of a Dual Antibody Immunoassay for hK2 with Negligible Prostate-Specific Antigen Cross-reactivity

Judith A. Finlay, Cindy L. Evans, John Day et al. · Urology · 1998 · 61 citations

, , +10

1–5 of 16